Literature DB >> 9427050

The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation.

E Rintala1, K Remes, T T Salmi, P Koskinen, J Nikoskelainen.   

Abstract

To evaluate the diagnostic utility of C-reactive protein (CRP) for the detection of sepsis in bone marrow transplantation, CRP levels were analyzed after pretransplant conditioning and variably combined in septic, focal or viral infections with graft-versus-host disease (GvHD) in 64 bone marrow recipients. The CRP levels after pretransplant conditioning were low. The peak levels of CRP were influenced independently by the type of infection (p = 0.016; septic and viral infections were significantly different) and GvHD (p = 0.003). The area under the receiver-operator characteristic (ROC) curve for peak CRP in sepsis was 0.653 and 0.618 with and without GvHD, respectively. It was concluded that GvHD and the type of infection were independent determinants of the CRP responses. GvHD did not affect the extent of the CRP response. Therefore, although not highly specific for sepsis, CRP remains a useful detector of sepsis in bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427050     DOI: 10.1007/bf01740812

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  13 in total

1.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

2.  Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.

Authors:  U M Saarinen; S E Strandjord; P I Warkentin; N K Cheung; H M Lazarus; P F Coccia
Journal:  Transplantation       Date:  1987-10       Impact factor: 4.939

3.  C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.

Authors:  P C Ligtenberg; I M Hoepelman; G A Oude Sogtoen; A W Dekker; I van der Tweel; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

4.  Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia.

Authors:  P Riikonen; U M Saarinen; A M Teppo; K Metsärinne; F Fyhrquist; H Jalanko
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

5.  Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation.

Authors:  H Tilg; J Nordberg; W Vogel; T A Luger; M Herold; W E Aulitzky; R Margreiter; C Huber
Journal:  Transplantation       Date:  1992-07       Impact factor: 4.939

6.  A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia.

Authors:  F A Manian
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

7.  Serum C-reactive protein concentrations in cyclosporine-treated renal allograft recipients.

Authors:  D J Cohen; A I Benvenisty; E Meyer; M A Hardy
Journal:  Transplantation       Date:  1988-05       Impact factor: 4.939

8.  Value of measurement of C-reactive protein in febrile patients with hematological malignancies.

Authors:  E Rintala; K Irjala; J Nikoskelainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

9.  Serial study of C-reactive protein during infection in leukaemia.

Authors:  P E Rose; S A Johnsdon; M Meakin; P H Mackie; J Stuart
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

10.  Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.

Authors:  E Rintala; K Pulkki; J Mertsola; T Nevalainen; J Nikoskelainen
Journal:  Scand J Infect Dis       Date:  1995
View more
  1 in total

1.  Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study.

Authors:  Pedro Póvoa; Luís Coelho; Eduardo Almeida; Antero Fernandes; Rui Mealha; Pedro Moreira; Henrique Sabino
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.